We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.36%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$4.51B
AUM Growth
+$737M
Cap. Flow
+$736M
Cap. Flow %
16.32%
Top 10 Hldgs %
19.25%
Holding
501
New
284
Increased
70
Reduced
66
Closed
74

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$99.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$80.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$77.7M
4
EA icon
Electronic Arts
EA
+$61.9M
5
DHR icon
Danaher
DHR
+$60.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$99.3M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$97.8M
3
MDT icon
Medtronic
MDT
+$68.7M
4
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
5
LITE icon
Lumentum
LITE
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 47.83%
2 Technology 26.25%
3 Communication Services 6.68%
4 Consumer Discretionary 4.05%
5 Financials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRVN icon
201
Driven Brands
DRVN
$2.4B
$4.62M 0.1%
+181,710
New +$5.15M
IRON icon
202
Disc Medicine
IRON
$2.93B
$4.58M 0.1%
+11,277
New +$5.03M
OBIO icon
203
Orchestra BioMed
OBIO
$247M
$4.52M 0.1%
403,699
– –
HAYW icon
204
Hayward Holdings
HAYW
$3.28B
$4.48M 0.1%
+265,257
New +$4.43M
TIXT
205
DELISTED
TELUS International
TIXT
$4.48M 0.1%
+160,000
New +$4.68M
PDOT.U
206
DELISTED
Peridot Acquisition Corp. II Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
PDOT.U
$4.47M 0.1%
+450,000
New +$4.48M
TPTX
207
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$4.37M 0.1%
+46,200
New +$5.49M
RBLX icon
208
Roblox
RBLX
$26.2B
$4.24M 0.09%
+65,323
New +$4.55M
DGNU
209
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$4.04M 0.09%
+400,000
New +$4.04M
ASZ.U
210
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
$4.01M 0.09%
+400,000
New +$4.06M
GH icon
211
Guardant Health
GH
$21.3B
$4M 0.09%
26,213
+2,370
+10% +$358K
HIIIU
212
DELISTED
Hudson Executive Investment Corp. III Unit
HIIIU
$3.97M 0.09%
+400,000
New +$4.02M
DTOCU
213
DELISTED
Digital Transformation Opportunities Corp. Units
DTOCU
$3.96M 0.09%
+400,000
New +$3.98M
ACHL
214
DELISTED
Achilles Therapeutics
ACHL
$3.95M 0.09%
+238,822
New +$3.95M
KDMN
215
DELISTED
Kadmon Holdings, Inc.
KDMN
$3.88M 0.09%
996,495
-2,853,348
-74% -$13.1M
XM
216
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$3.86M 0.09%
+117,368
New +$4.76M
ZIM icon
217
ZIM Integrated Shipping Services
ZIM
$3.14B
$3.85M 0.09%
+158,135
New +$3.26M
RXDX
218
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$3.84M 0.09%
+210,324
New +$4.34M
FRGE
219
DELISTED
Forge Global Holdings
FRGE
$3.83M 0.08%
+26,051
New +$4.01M
WBA
220
DELISTED
Walgreens Boots Alliance
WBA
$3.83M 0.08%
+69,686
New +$3.44M
CLAA.U
221
DELISTED
Colonnade Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant
CLAA.U
$3.8M 0.08%
+386,122
New +$3.85M
FDMT icon
222
4D Molecular Therapeutics
FDMT
$527M
$3.72M 0.08%
85,829
-17,624
-17% -$781K
TBIO
223
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3.72M 0.08%
225,683
+80,840
+56% +$1.84M
INFN
224
DELISTED
Infinera Corporation Common Stock
INFN
$3.67M 0.08%
+380,770
New +$3.73M
SEEL
225
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$3.55M 0.08%
+185
New +$2.16M
7 8
9
10 11

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return

Woodline Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Woodline Partners held 501 positions worth $4.51B, up 20% from $3.77B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $736M of net new capital in Q1 2021, opening 284 new positions and adding to 70 existing holdings. Its largest new stake was Gilead Sciences: 1,541,893 shares worth $99.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 43% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amgen, an estimated $99.3M trimmed.

  • Woodline Partners's largest Q1 2021 buy was Gilead Sciences: 1,541,893 shares worth $99.7M.
  • Woodline Partners added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $80.7M increase.
  • Woodline Partners's biggest Q1 2021 reduction was Amgen, cutting an estimated $99.3M.
  • Woodline Partners fully exited Alphabet (Google) Class A in Q1 2021, selling an estimated $97.8M.
  • Woodline Partners's ten largest holdings make up 19% of its $4.51B portfolio in Q1 2021.
  • Woodline Partners opened 284 new positions and closed 74 in Q1 2021.
  • Woodline Partners's portfolio value rose 20% quarter-over-quarter to $4.51B.

Based on Woodline Partners's 13F filing for Q1 2021, filed 17 May 2021.